| http://dbpedia.org/ontology/abstract
|
Bausch Health Companies Inc. est une entreprise pharmaceutique dont le siège social est situé à Laval (Québec, Canada).
, Bausch Health Companies Inc. (formerly Val … Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is a Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. The company in its present form is the result of a merger between Valeant and Canadian firm Biovail. The company retained the Valeant name and J. Michael Pearson as CEO, but was incorporated in Canada and kept Biovail's headquarters. Valeant was originally founded in 1959 as ICN Pharmaceuticals by Milan Panić in California. Under the leadership of J. Michael Pearson, Valeant adopted a strategy of buying up other pharmaceutical companies which manufactured effective medications for a variety of medical problems, and then increasing the price of those medications. As a result, the company grew rapidly and in 2015 was the most valuable company in Canada. Its largest acquisitions were Bausch & Lomb, in 2013, and Salix Pharmaceuticals, in 2015. Valeant also tried to acquire Actavis and Cephalon. An attempted merger with Allergan, in 2014, failed and resulted in the company being sued for insider trading prior to their bid. In 2015, Valeant was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs. This led to an investigation by the U.S. Securities and Exchange Commission, causing its stock price to plummet more than 90 percent from its peak, while its debt surpassed $30 billion. In 2016, Pearson was ousted and replaced by Joseph C. Papa, while investor Bill Ackman joined the board. In 2017, Ackman's Pershing Square fund, which held a major stake in the company, sold out for a reported loss of $2.8 billion. Following Ackman's exit, Paulson & Co. increased its stake in the company, became its largest shareholder, with its founder, John Paulson, joining the board, and vowing to rebuild the company's core franchises and to reduce its debt. Under Papa's leadership, by early 2018, the company had become profitable again; had settled the Allergan case for less than expected; and had lowered its debt by $6.5 billion. In July 2018, the name of the company was changed to Bausch Health Companies Inc., in order to distance itself from the public outrage associated with massive price increases introduced by Valeant. At the same time, a new ticker symbol, BHC replaced VRX. In December 2019, the company settled a shareholder class action lawsuit under Section 11 of the U.S. Securities Act of 1933, alleging the company misled investors about its business operations and financial performance, for approximately $1.2 billion.rformance, for approximately $1.2 billion.
, Bausch Health Companies («Бауш Хэлс Компан … Bausch Health Companies («Бауш Хэлс Компаниз»)— международная канадская фармацевтическая группа со штаб-квартирой в Лавале, входящий в состав мегаполиса Большой Монреаль. В списке крупнейших публичных компаний мира Forbes Global 2000 за 2021 год Bausch Health заняла 1410-е место (1252-е по обороту, 1046-е по активам и 1602-е по рыночной капитализации.ктивам и 1602-е по рыночной капитализации.
, Bausch Health (ehemals Valeant Pharmaceuti … Bausch Health (ehemals Valeant Pharmaceuticals International) ist ein international tätiges pharmazeutisches Unternehmen mit Hauptsitz in Laval in der Provinz Québec nahe Montreal (Kanada). Bausch Health wird an der Börse von Toronto (TSX) und an der New Yorker Börse (NYSE) jeweils unter dem Symbol „BHC“ gehandelt. Es erforscht, entwickelt und produziert Pharmazeutika und vermarktet patentgeschützte Arzneimittel, Generika und rezeptfreie Arzneimittel in den Indikationsbereichen Dermatologie und Augenheilkunde. Das Unternehmen wurde 1960 gegründet und erzielte 2013 mit 7.500 Mitarbeitern einen weltweiten Umsatz von ca. 5,8 Mrd. US-Dollar. Der schwedische Pharmakonzern Meda AB erwarb im Jahre 2008 Geschäftsbereiche von Valeant in West- und Osteuropa für 392 Millionen US-Dollar. Dadurch existiert u. a. auch keine deutsche Tochtergesellschaft mehr. Die ehemaligen Valeant-Produkte werden in Deutschland zwischenzeitlich von der MEDA Pharma Deutschland (Bad Homburg) vertrieben. Im Jahre 2010 verschmolz Valeant mit dem ebenfalls kanadischen Pharmazeutik-Konzern Biovail, dabei wurde die Biovail Corporation in Valeant umbenannt. Im Mai 2013 wurde das US-amerikanische Unternehmen Bausch & Lomb an Valeant verkauft. 2015 gab das Unternehmen bekannt, den Wettbewerber Salix Pharmaceuticals für 14,5 Mrd. US-Dollar zu übernehmen. Dies ist für Valeant der größte Zukauf der Firmengeschichte.Im August gaben Valeant und Sprout Pharmaceuticals bekannt, dass man sich auf eine Übernahme von Sprout durch Valeant geeinigt habe. Im vierten Quartal des Jahres solle eine Tochterfirma von Valeant für rund eine Milliarde US-Dollar das Unternehmen Sprout übernehmen. Sprout war zur gleichen Zeit mit dem Medikament Addyi („Viagra für die Frau“) ins mediale Interesse getreten. Am 21. Oktober 2015 geriet Valeant in den Verdacht, seine Bilanzen manipuliert zu haben. Die Aktie verlor daraufhin 40 Prozent ihres Wertes und wurde kurzzeitig vom Handel ausgesetzt. Der Kursverlust von Mitte September 2015 bis April 2017 liegt bei mehr als 95 Prozent. In Folge des Bilanzskandals wurde 2016 die Konzernführung ausgewechselt und im Juli 2018 der Name zu Bausch Health Companies geändert. Name zu Bausch Health Companies geändert.
|
| http://dbpedia.org/ontology/assets
|
2.92E10
|
| http://dbpedia.org/ontology/equity
|
-3.4E7
|
| http://dbpedia.org/ontology/foundedBy
|
http://dbpedia.org/resource/Milan_Pani%C4%87 +
|
| http://dbpedia.org/ontology/foundingYear
|
1959
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Pharmaceutical_industry +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Thomas_J._Appio +
, http://dbpedia.org/resource/John_Paulson +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Vice_president +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Laval%2C_Quebec +
|
| http://dbpedia.org/ontology/netIncome
|
-9.37E8
|
| http://dbpedia.org/ontology/numberOfEmployees
|
2021
|
| http://dbpedia.org/ontology/operatingIncome
|
4.5E8
|
| http://dbpedia.org/ontology/revenue
|
8.43E9
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Bausch_Health_logo.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.bauschhealth.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
2350163
|
| http://dbpedia.org/ontology/wikiPageLength
|
61824
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1119448054
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Eugene_Melnyk +
, http://dbpedia.org/resource/Ribavirin +
, http://dbpedia.org/resource/Milan_Pani%C4%87 +
, http://dbpedia.org/resource/Penicillamine +
, http://dbpedia.org/resource/Joseph_C._Papa +
, http://dbpedia.org/resource/Berkshire_Hathaway +
, http://dbpedia.org/resource/Flucytosine +
, http://dbpedia.org/resource/Fungus +
, http://dbpedia.org/resource/Contact_lens +
, http://dbpedia.org/resource/Specialty_pharmacy +
, http://dbpedia.org/resource/Generic_drug +
, http://dbpedia.org/resource/Periodontitis +
, http://dbpedia.org/resource/Bill_Ackman +
, http://dbpedia.org/resource/United_States_House_Committee_on_Oversight_and_Government_Reform +
, http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/Skin_disease +
, http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/Ticker_symbol +
, http://dbpedia.org/resource/CE_Mark +
, http://dbpedia.org/resource/Sports_nutrition +
, http://dbpedia.org/resource/L%27Or%C3%A9al +
, http://dbpedia.org/resource/AstraZeneca +
, http://dbpedia.org/resource/Paulson_&_Co. +
, http://dbpedia.org/resource/Cystine +
, http://dbpedia.org/resource/Portfolio_manager +
, http://dbpedia.org/resource/Multinational_company +
, http://dbpedia.org/resource/Vice_president +
, http://dbpedia.org/resource/Bausch_&_Lomb +
, http://dbpedia.org/resource/Medicis_Pharmaceutical +
, http://dbpedia.org/resource/Metformin +
, http://dbpedia.org/resource/Subpoena +
, http://dbpedia.org/resource/Pharmaceutical_product +
, http://dbpedia.org/resource/J._Michael_Pearson +
, http://dbpedia.org/resource/Isoprenaline +
, http://dbpedia.org/resource/Colitis +
, http://dbpedia.org/resource/Dermatology +
, http://dbpedia.org/resource/Gastrointestinal +
, http://dbpedia.org/resource/Pharmaceutical_industry +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Canada +
, http://dbpedia.org/resource/Pharmaceutical_company +
, http://dbpedia.org/resource/Biovail +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Antibiotic +
, http://dbpedia.org/resource/United_States_Attorney_for_the_Southern_District_of_New_York +
, http://dbpedia.org/resource/T-Cell +
, http://dbpedia.org/resource/CFO +
, http://dbpedia.org/resource/Walgreens +
, http://dbpedia.org/resource/Prescription_drug +
, http://dbpedia.org/resource/Mood_disorder +
, http://dbpedia.org/resource/Market_capitalisation +
, http://dbpedia.org/resource/Joe_Nocera +
, http://dbpedia.org/resource/Category:1959_establishments_in_California +
, http://dbpedia.org/resource/Tretinoin +
, http://dbpedia.org/resource/Nestle +
, http://dbpedia.org/resource/Neurology +
, http://dbpedia.org/resource/Meda_AB +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Actavis +
, http://dbpedia.org/resource/Price_gouging +
, http://dbpedia.org/resource/Diabetes +
, http://dbpedia.org/resource/Dirty_Money_%282018_TV_series%29 +
, http://dbpedia.org/resource/Solta_Medical +
, http://dbpedia.org/resource/Type_2_diabetes_mellitus +
, http://dbpedia.org/resource/Skin-care +
, http://dbpedia.org/resource/Allergan +
, http://dbpedia.org/resource/Glycemic_control +
, http://dbpedia.org/resource/Gastrointestinal_disorder +
, http://dbpedia.org/resource/Huntington%E2%80%99s_disease +
, http://dbpedia.org/resource/OraPharma +
, http://dbpedia.org/resource/Thomas_J._Appio +
, http://dbpedia.org/resource/Securities_Act_of_1933 +
, http://dbpedia.org/resource/File:Valeant_Pharmaceuticals%27_Business_Model_%2826410186110%29_%28cropped%29.jpg +
, http://dbpedia.org/resource/File:Valeant_Pharmaceuticals%27_Business_Model_%2826683524705%29_%28cropped%29.jpg +
, http://dbpedia.org/resource/File:Bill_Ackman_%2826410186110%29_%28cropped%29.jpg +
, http://dbpedia.org/resource/File:Milan_Pani%C4%87.JPG +
, http://dbpedia.org/resource/Glumetza +
, http://dbpedia.org/resource/Hypertensive +
, http://dbpedia.org/resource/Tetrabenazine +
, http://dbpedia.org/resource/Sodium_nitroprusside +
, http://dbpedia.org/resource/Rigid_gas_permeable +
, http://dbpedia.org/resource/Addyi +
, http://dbpedia.org/resource/Proxy_firm +
, http://dbpedia.org/resource/Benzoyl_peroxide/clindamycin +
, http://dbpedia.org/resource/Dry_eyes +
, http://dbpedia.org/resource/Short_seller +
, http://dbpedia.org/resource/Joseph_Papa +
, http://dbpedia.org/resource/Ocular_surgery +
, http://dbpedia.org/resource/Eye_surgery +
, http://dbpedia.org/resource/Nitropress +
, http://dbpedia.org/resource/Sanitas +
, http://dbpedia.org/resource/Antiviral +
, http://dbpedia.org/resource/Cesamet +
, http://dbpedia.org/resource/John_Paulson +
, http://dbpedia.org/resource/Lymphoma +
, http://dbpedia.org/resource/Holding_company +
, http://dbpedia.org/resource/Irritable_bowel_syndrome +
, http://dbpedia.org/resource/Category:S&P/TSX_60 +
, http://dbpedia.org/resource/Psoriasis +
, http://dbpedia.org/resource/Corticosteroid +
, http://dbpedia.org/resource/Bupropion +
, http://dbpedia.org/resource/Category:Specialty_drugs +
, http://dbpedia.org/resource/Chorea +
, http://dbpedia.org/resource/Budesonide +
, http://dbpedia.org/resource/Comptroller +
, http://dbpedia.org/resource/Glass_Lewis +
, http://dbpedia.org/resource/Class_action +
, http://dbpedia.org/resource/Wilson%27s_disease +
, http://dbpedia.org/resource/Insider_trading +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/United_States_District_Court_for_the_District_of_Massachusetts +
, http://dbpedia.org/resource/Perrigo +
, http://dbpedia.org/resource/Salix_Pharmaceuticals +
, http://dbpedia.org/resource/Over_the_counter_drug +
, http://dbpedia.org/resource/Andrew_Left +
, http://dbpedia.org/resource/United_States_Securities_and_Exchange_Commission +
, http://dbpedia.org/resource/Ophthalmology +
, http://dbpedia.org/resource/Viking_Global_Investors +
, http://dbpedia.org/resource/Blood_pressure +
, http://dbpedia.org/resource/Sanofi +
, http://dbpedia.org/resource/Short_%28finance%29 +
, http://dbpedia.org/resource/Category:Tax_inversions +
, http://dbpedia.org/resource/Warburg_Pincus +
, http://dbpedia.org/resource/Libido +
, http://dbpedia.org/resource/Laval%2C_Quebec +
, http://dbpedia.org/resource/Dendreon +
, http://dbpedia.org/resource/Cephalon +
, http://dbpedia.org/resource/Diarrhea +
, http://dbpedia.org/resource/Walgreens_Boots_Alliance +
, http://dbpedia.org/resource/New_York_Stock_Exchange +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_based_in_New_Jersey +
, http://dbpedia.org/resource/Annual_report +
, http://dbpedia.org/resource/The_New_York_Times +
, http://dbpedia.org/resource/Hedge_fund +
, http://dbpedia.org/resource/S&P/TSX_60 +
, http://dbpedia.org/resource/Twitter +
, http://dbpedia.org/resource/Category:Canadian_brands +
, http://dbpedia.org/resource/Cystinuria +
, http://dbpedia.org/resource/Isuprel +
, http://dbpedia.org/resource/Retin-A +
, http://dbpedia.org/resource/Rifaximin +
, http://dbpedia.org/resource/North_Carolina_Department_of_Justice +
, http://dbpedia.org/resource/Bexarotene +
, http://dbpedia.org/resource/Category:Companies_based_in_Laval%2C_Quebec +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1959 +
, http://dbpedia.org/resource/Triethylenetetramine +
, http://dbpedia.org/resource/Ertaczo +
, http://dbpedia.org/resource/Loteprednol +
, http://dbpedia.org/resource/Brodalumab +
, http://dbpedia.org/resource/Efinaconazole +
, http://dbpedia.org/resource/Pasadena +
, http://dbpedia.org/resource/Endo_Pharmaceuticals +
, http://dbpedia.org/resource/Ontario_Securities_Commission +
, http://dbpedia.org/resource/Clindamycin/tretinoin +
, http://dbpedia.org/resource/Acne +
, http://dbpedia.org/resource/Traveler%27s_diarrhea +
, http://dbpedia.org/resource/Hillary_Clinton +
, http://dbpedia.org/resource/U.S._Securities_and_Exchange_Commission +
, http://dbpedia.org/resource/Private_equity +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Toronto_Stock_Exchange +
, http://dbpedia.org/resource/House_Oversight_Committee +
, http://dbpedia.org/resource/Health_care_system +
, http://dbpedia.org/resource/Aciclovir +
, http://dbpedia.org/resource/Retinoid +
, http://dbpedia.org/resource/Dermatitis +
, http://dbpedia.org/resource/Infectious_disease +
, http://dbpedia.org/resource/European_Commission +
, http://dbpedia.org/resource/Pershing_Square_Capital_Management +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Pimecrolimus +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Federal_Trade_Commission +
, http://dbpedia.org/resource/Tazarotene +
, http://dbpedia.org/resource/Charlie_Munger +
, http://dbpedia.org/resource/Philidor_Rx_Services +
, http://dbpedia.org/resource/Benzoyl_peroxide +
, http://dbpedia.org/resource/Board_of_Directors +
, http://dbpedia.org/resource/Herpes +
, http://dbpedia.org/resource/Minocycline +
, http://dbpedia.org/resource/CEO +
|
| http://dbpedia.org/property/assets
|
2.92E10
|
| http://dbpedia.org/property/bloomberg
|
BHC:CA
|
| http://dbpedia.org/property/equity
|
-3.4E7
|
| http://dbpedia.org/property/founder
|
http://dbpedia.org/resource/Milan_Pani%C4%87 +
|
| http://dbpedia.org/property/google
|
BHC.TO
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Pharmaceutical_industry +
|
| http://dbpedia.org/property/isin
|
CA0717341071
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Thomas_J._Appio +
, http://dbpedia.org/resource/John_Paulson +
, Thomas G. Vadaketh
, John S. Barresi
|
| http://dbpedia.org/property/location
|
Laval, Quebec, Canada
|
| http://dbpedia.org/property/logo
|
Bausch Health logo.svg
|
| http://dbpedia.org/property/logoSize
|
250
|
| http://dbpedia.org/property/name
|
Bausch Health Companies Inc.
|
| http://dbpedia.org/property/netIncome
|
-9.37E8
|
| http://dbpedia.org/property/operatingIncome
|
4.5E8
|
| http://dbpedia.org/property/reuters
|
BHC.TO
|
| http://dbpedia.org/property/revenue
|
8.43E9
|
| http://dbpedia.org/property/secCik
|
885590
|
| http://dbpedia.org/property/symbol
|
BHC
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:TSX +
, http://dbpedia.org/resource/Template:Blockquote +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:CladeR +
, http://dbpedia.org/resource/Template:Clade_sequential +
, http://dbpedia.org/resource/Template:Circa +
, http://dbpedia.org/resource/Template:Primary_sources +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Finance_links +
, http://dbpedia.org/resource/Template:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Template:Official +
, http://dbpedia.org/resource/Template:Commons_category +
, http://dbpedia.org/resource/Template:Morningstar_National_Bank_Qu%C3%A9bec_Index +
, http://dbpedia.org/resource/Template:Decrease +
, http://dbpedia.org/resource/Template:S&P/TSX_60 +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Url +
, http://dbpedia.org/resource/Template:Clear_left +
, http://dbpedia.org/resource/Template:Ubl +
|
| http://dbpedia.org/property/yahoo
|
BHC.TO
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Canadian_brands +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Toronto_Stock_Exchange +
, http://dbpedia.org/resource/Category:1959_establishments_in_California +
, http://dbpedia.org/resource/Category:Specialty_drugs +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_based_in_New_Jersey +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Tax_inversions +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_Canada +
, http://dbpedia.org/resource/Category:Companies_based_in_Laval%2C_Quebec +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1959 +
, http://dbpedia.org/resource/Category:S&P/TSX_60 +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/306408134 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Bausch_Health?oldid=1119448054&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Bausch_Health_logo.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Valeant_Pharmaceuticals%27_Business_Model_%2826410186110%29_%28cropped%29.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Valeant_Pharmaceuticals%27_Business_Model_%2826683524705%29_%28cropped%29.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Milan_Pani%C4%87.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Bill_Ackman_%2826410186110%29_%28cropped%29.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.bauschhealth.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Bausch_Health +
|
| http://xmlns.com/foaf/0.1/name
|
Bausch Health Companies Inc.
|
| owl:sameAs |
http://azb.dbpedia.org/resource/%D9%88%D8%A7%D9%84%DB%8C%D9%86%D8%AA +
, http://www.wikidata.org/entity/Q1700871 +
, http://fa.dbpedia.org/resource/%D9%88%D8%A7%D9%84%DB%8C%D9%86%D8%AA +
, http://viaf.org/viaf/306408134 +
, http://dbpedia.org/resource/Bausch_Health +
, http://ru.dbpedia.org/resource/Bausch_Health +
, http://fr.dbpedia.org/resource/Bausch_Health +
, http://uz.dbpedia.org/resource/Bausch_Health +
, https://global.dbpedia.org/id/foe3 +
, http://de.dbpedia.org/resource/Bausch_Health +
, http://fi.dbpedia.org/resource/Bausch_Health +
|
| rdf:type |
http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://schema.org/Organization +
|
| rdfs:comment |
Bausch Health Companies («Бауш Хэлс Компан … Bausch Health Companies («Бауш Хэлс Компаниз»)— международная канадская фармацевтическая группа со штаб-квартирой в Лавале, входящий в состав мегаполиса Большой Монреаль. В списке крупнейших публичных компаний мира Forbes Global 2000 за 2021 год Bausch Health заняла 1410-е место (1252-е по обороту, 1046-е по активам и 1602-е по рыночной капитализации.ктивам и 1602-е по рыночной капитализации.
, Bausch Health Companies Inc. est une entreprise pharmaceutique dont le siège social est situé à Laval (Québec, Canada).
, Bausch Health (ehemals Valeant Pharmaceuti … Bausch Health (ehemals Valeant Pharmaceuticals International) ist ein international tätiges pharmazeutisches Unternehmen mit Hauptsitz in Laval in der Provinz Québec nahe Montreal (Kanada). Bausch Health wird an der Börse von Toronto (TSX) und an der New Yorker Börse (NYSE) jeweils unter dem Symbol „BHC“ gehandelt. Es erforscht, entwickelt und produziert Pharmazeutika und vermarktet patentgeschützte Arzneimittel, Generika und rezeptfreie Arzneimittel in den Indikationsbereichen Dermatologie und Augenheilkunde.bereichen Dermatologie und Augenheilkunde.
, Bausch Health Companies Inc. (formerly Val … Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is a Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.; Lomb, a supplier of eye health products.
|
| rdfs:label |
Bausch Health
|
